Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Biologics: Targets & Therapy · 2008-09 · 345
DOI: 10.2147/btt.s3394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics: Targets & Therapy, 2008-09. Verfasst von Neil Ghodadra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
Zitieren
APA
Ghodadra, N., & Singh, K. (2008). Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biologics: Targets & Therapy, 345. https://doi.org/10.2147/btt.s3394
Vancouver
Ghodadra N, Singh K. Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biologics: Targets & Therapy. 2008:345. doi:10.2147/btt.s3394
BibTeX
@article{Ghodadra2008,
author = {Ghodadra, Neil and Singh, Kern},
title = {Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures},
journal = {Biologics: Targets & Therapy},
year = {2008},
pages = {345},
doi = {10.2147/btt.s3394}
}
EUVIMED